PAT — A Framework For Innovative Pharmaceutical Development, Manufacturing, And Quality Assurance

This guidance is intended to describe a regulatory framework (Process Analytical Technology, PAT) that will encourage the voluntary development and implementation of innovative pharmaceutical development, manufacturing, and quality assurance. Working with existing regulations, the Agency has developed an innovative approach for helping the pharmaceutical industry address anticipated technical and regulatory issues and questions. Submitted by the Food and Drug Administration (FDA)